Empagliflozin
Drugs used in diabetes | Endocrine System
Items (National)
4.3M
NHS Cost
£163.5M
Practices
6,852
Avg per Practice
626
Overview
Empagliflozin is prescribed by 6,852 GP practices across England. In the last 12 months, 4,288,107 items were prescribed at a total cost of £163,486,606 to the NHS. It is classified under BNF Chapter Endocrine System, Section Drugs used in diabetes.
Monthly Prescribing Trend
Jun 2026
340,867
Jun 2026
323,207
Jun 2026
357,620
Jun 2026
348,967
Jun 2026
344,911
Jun 2026
366,955
Jun 2026
356,636
Jun 2026
368,911
Jun 2026
380,970
Jun 2026
344,680
Jun 2026
370,078
Jun 2026
376,695
Prescribing by Area
| Area | Items | Practices | Avg/Practice | vs National |
|---|---|---|---|---|
| S | 186.4K | 171 | 1,090 | +74.2% ▲ |
| B | 157.2K | 261 | 602 | -3.8% ▼ |
| LE | 140.0K | 125 | 1,120 | +79.0% ▲ |
| E | 124.0K | 141 | 879 | +40.5% ▲ |
| NG | 108.7K | 138 | 788 | +25.9% ▲ |
| M | 106.0K | 172 | 616 | -1.5% vs avg |
| DN | 89.1K | 92 | 968 | +54.7% ▲ |
| RG | 88.5K | 66 | 1,341 | +114.2% ▲ |
| LS | 85.6K | 90 | 951 | +52.0% ▲ |
| DE | 84.4K | 81 | 1,042 | +66.4% ▲ |
| UB | 78.8K | 71 | 1,110 | +77.4% ▲ |
| CV | 77.0K | 110 | 700 | +11.9% ▲ |
| HU | 76.3K | 43 | 1,775 | +183.7% ▲ |
| TS | 75.8K | 72 | 1,053 | +68.2% ▲ |
| NN | 69.9K | 65 | 1,076 | +71.9% ▲ |
| BB | 66.1K | 68 | 972 | +55.4% ▲ |
| BD | 65.8K | 58 | 1,134 | +81.2% ▲ |
| PE | 65.0K | 92 | 707 | +13.0% ▲ |
| N | 60.8K | 117 | 520 | -16.9% ▼ |
| BN | 59.6K | 77 | 774 | +23.6% ▲ |
Top Prescribing Practices
| Practice | Items |
|---|---|
| MEDICUS HEALTH PARTNERS | 10,878 |
| HULL FAMILY PRACTICE | 10,034 |
| THE SALUJA CLINIC | 8,198 |
BNF Classification
- Chapter: Endocrine System
- Section: Drugs used in diabetes
- Paragraph: Antidiabetic drugs
Related drugs in this section
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.